Tissue bank for human blood cell disorders
Official title: Human Blood Cell Disorders Tissue Bank
Run by Northwell Health · NCT00902447 · Data updated 2026-11-12
This study is creating a tissue bank of blood samples from patients with blood cell disorders so researchers can learn more about these conditions and how they compare to healthy blood cells.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Northwell Health Academic / other |
| Locations | 1 site (Manhasset, New York) |
| Status | Recruiting |
| Started | April 2009 |
| Main results expected | January 2030 |
| Study ends | January 2035 |
| Registry record updated | March 27, 2024 |
| Trial ID | NCT00902447 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients diagnosed with lymphoid, myeloid, or erythroid proliferative diseases who can provide informed consent and contribute tissue samples.
✕Probably not a fit
Patients who are anemic with hemoglobin levels below 8.0 g/dl or those infected with HIV may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Human Blood Cell Disorder Tissue Bank aims to create a comprehensive repository of tissue samples containing various populations of human blood cells from patients with lymphoid, myeloid, and erythroid proliferative diseases. This observational study will allow internal and external researchers to access these samples to investigate the immunologic, virologic, genetic, and molecular characteristics of both abnormal and normal blood cells. The goal is to enhance understanding of blood cell disorders and facilitate better comparisons with normal cellular counterparts.
Why it matters
Potential benefit: If successful, this tissue bank could significantly advance the understanding and treatment of various blood cell disorders.
How similar studies have gone: While similar tissue banks have been established, the specific focus on human blood cell disorders may provide novel insights into these conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants or participant's Legally Authorized Representatives (LAR) must be able to understand and render voluntary, written informed consent. * Patients must be able to contribute the required amount of blood and/or tissue without compromising their well-being or care. * Participants must be willing to be contacted again for consideration of additional studies in the future, such as a blood draw or another action (e.g., bone marrow aspiration and/or biopsy) that would be done as part of their standard of care. Exclusion Criteria: * Patients who are known to be anemic, with hemoglobin \<8.0g/dl. * Patients who are known to be infected with HIV.
Where it's running
-
The Feinstein Institute for Medical Research
Manhasset, New York, United States Recruiting
Study contacts
- Principal investigator: Nicholas Chiorazzi, M.D. — Northwell Health
- Study coordinator: Yasmine Kieso, MSCR
- Email: ykieso@northwell.edu
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain connectome project in adults with brain glioma undergoing surgery
This registry collects MRI data and clinical information from adults with glioma to see how brain networks relate to surgery and recovery.
-
Pain relief during urethral bulking: comparing lidocaine versus saline injections
We’re testing whether injecting lidocaine around the urethra reduces pain more than a saline placebo during urethral bulking for stress urinary incontinence.
-
Increased fruit juice for better exercise ability and lower inflammation
This study will test whether drinking two fruit juice beverages daily for two weeks can influence inflammatory markers and how far people can walk in six minutes.
-
Breast Artery Calcification and Heart Health in Women
This study tests whether a breast artery calcification finding on a mammogram is linked to different cardiovascular markers in women 55–65 who do or do not have BAC.
-
Vagustim taVNS: Testing a sham in adults for immune-related conditions
This small, double-blind study tests whether Vagustim taVNS’s sham method works as a believable placebo in healthy adults.
-
Brain-derived miRNA biomarkers in first-episode psychosis
Researchers will test whether specific brain-derived microRNAs in blood can help identify schizophrenia early and track treatment in people with first-episode psychosis on aripiprazole or risperidone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.